Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s November Goal Dates Cannot Elevate 2024’s Novel Approvals To 2023 Levels
Nov 01 2024
•
By
Bridget Silverman
The FDA's November calendar includes user fee goal dates for six novel agents.
(Shutterstock)
More from User Fee Goal Dates
More from United States